Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells

Ilaria Guerriero; Daniela D’Angelo; Pierlorenzo Pallante; Mafalda Santos; Marianna Scrima; Donatella Malanga; Carmela De Marco; Maria Ravo; Alessandro Weisz; Carmelo Laudanna; Michele Ceccarelli; Geppino Falco; Antonia Rizzuto; Giuseppe Viglietto

doi:10.18632/oncotarget.28237

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells

PDF | How to cite

Oncotarget. 2022; 13:755-755. https://doi.org/10.18632/oncotarget.28237

Metrics: PDF 985 views | ?

Ilaria Guerriero¹, Daniela D’Angelo², Pierlorenzo Pallante², Mafalda Santos¹, Marianna Scrima¹, Donatella Malanga³, Carmela De Marco³, Maria Ravo⁴, Alessandro Weisz⁴, Carmelo Laudanna³, Michele Ceccarelli^1,5, Geppino Falco^1,6, Antonia Rizzuto⁷, and Giuseppe Viglietto^1,3

¹Biogems.c.ar.l., Istituto di Ricerche Genetiche “Gaetano Salvatore”, Ariano Irpino, Avellino, Italy
²Istituto per l’Endocrinologia e l’Oncologia Sperimentale, IEOS-CNR, c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università “Federico II” of Napoli, Napoli, Italy
³Dipartimento di Medicina Sperimentale e Clinica, Università Magna Graecia of Catanzaro, Italy
⁴Laboratorio di Medicina Molecolare e Genomica, Dipartimentodi Medicina e Chirurgia, Università di Salerno, Baronissi, Italy
⁵Department of Biological and Environmental Studies, Università del Sannio, Benevento, Italy
⁶Dipartimento di Biologia, Università degli Studi di Napoli Federico II, Complesso Universitario Monte S.Angelo, Napoli, Italy
⁷Dipartimento di Scienze Mediche e Chirurgiche, Università Magna Graecia of Catanzaro, Italy

Published: May 25, 2022

Copyright: © 2022 Guerriero et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: In Figure 6B, the H460-SCR-EV image (upper left panel) contains accidental overlaps from the H460-shAKT1-miR-196a image (lower right panel). The corrected Figure 6B, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:19172–19191. DOI: https://doi.org/10.18632/oncotarget.13432

Figure 6: MiR-196a regulates migration and tumorigenicity of NSCLC cells. (B) Boyden chamber migration assay of control NCI-H460-SCR-EV, NCI-H460-shAKT1-EV, NCI-H460-SCR-antimiR-196a and NCI-H460-shAKT1-miR-196a cells. The graph represents the mean number (±SD) of migrated cells/field. Representative images of migrated NCI-H460 and derivative cells. Magnification 10×; p < 0.001.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28237

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells